Notice on Phase 2 Trial of Ferric Maltol by Consolidated Subsidiary for Pulmonary Hypertension Associated with Chronic Pulmonary Disease11/9 14:00TDnetPDF(160KB)
Notice Regarding Revision of Full-Year Earnings Forecast for Fiscal Year Ending March 202711/9 14:00TDnetPDF(107KB)
Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2027 [Japanese GAAP]11/9 14:00TDnetPDF(415KB)
[Summary]Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2027 [Japanese GAAP]8/6 14:00TDnetPDF(482KB)
Notice Regarding Recognition of Gain on Sale of Investment Securities (Extraordinary Income)7/27 16:00TDnetPDF(89KB)
Notice Regarding Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation7/24 14:00TDnetPDF(89KB)
Notice Regarding Disposition of Treasury Stock for Performance-Linked Restricted Stock Compensation6/25 14:00TDnetPDF(100KB)